Compare Montana Molecular vs Population Genetics Technologies
Customers evaluate the quality of Montana Molecular's products using the following success metrics.
Overview
Montana Molecular is 20 yrs old and is based in United States.
Montana Molecular is a company focused on the development of genetically encoded fluorescent biosensors and probes, operating within the biotechnology and drug discovery sectors. The company's main offerings include fluorescent assays for live cell discovery, which are used to observe and measure cell processes that are crucial in maintaining health and treating diseases. These products and services are primarily targeted towards the drug discovery and research industries. It was founded in 2004 and is based in Bozeman, Montana.
Population Genetics Technologies is 19 yrs old and is based in United Kingdom.
Population Genetics Technologies (PGT) develops technologies that aim to transform the economic viability of performing large scale genetic population studies and allow the detection and characterization of rare allelic variants increasingly thought to play a major role in the development of many disease states.
Demo Video
Leadership
Anne Marie Quinn (Chief Executive Officer)
Funding
Investors
TechRanch
Auriga, Compass Genetics Investors
Product
Why Montana Molecular beats Population Genetics Technologies
Information not available because Population Genetics Technologies has not claimed their profile.
Work for Population Genetics Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Population Genetics Technologies?
Claim your profile now.
Benefits
- Peer reviewed publications
- Results from pilot projects
- Multimedia protocols
Products
SARS CoV-2 Pseudoviruses
These pseudoviruses are BSL-1 baculoviruses pseudotyped with Spike (S) proteins. This means that biologists and drug discovery teams can work on COVID-19 projects outside of BSL-3 facilities with standard safety procedures.
Customers
Known Partners
Why They Buy